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In recent years, there have been a variety of advances in
vitreoretinal interface (VRI) disorders. Multimodal imaging,
such as spectral domain and swept source optical coherence
tomography (OCT), allows for enhanced visualization of vit-
reous evolution and leads to a better understanding of VRI
diseases in terms of both their diagnosis and management.
However, the role of vitreous per se in these diseases has been
neglected. Q. Ghadiali et al. tried to evaluate the impact of the
vitreous body and the extent of its degeneration in eyes with
vitreomacular traction (VMT) and macular hole (MH),
showing that the eyes with VMT and MH demonstrated ear-
lier stages of vitreous degeneration when compared to the
control eyes, despite significantly greater age. The authors
concluded that VRI diseases are more often associated with
a formed vitreous and an intact premacular bursa. They
hypothesized that the state of the vitreous itself may play a
role in the aetiology of VMT, in addition to the strength of
vitreoretinal adhesion, contrary to previous assumptions
implicating degeneration of vitreous as a precipitating factor
of VRI disease when in conjunction with abnormal vitreoma-
cular separation.
Additionally, posterior vitreous detachment (PVD) can
act as a protecting factor in cases with endogenous endoph-
thalmitis. K. Umazume et al. retrospectively studied ten
patients with endogenous endophthalmitis and found that
despite an advanced age during the vitrectomy, PVD was
absent in 80%, 50% of which showed retinal necrosis, sup-
porting that the state of vitreous attachment may be related
to the occurrence of endogenous endophthalmitis. In fact,
the authors suggested that the contact between the retina
and the vitreous body may be associated with severe disease
and proposed that the gel-like vitreous body may play the
role as a growth medium for the causative microorganisms.
On the other hand, there have also been many advances
in surgical techniques for the treatment of VRI diseases. U.
Soiberman et al. in a retrospective study of 74 eyes compared
the outcome of MH surgery with that of ILM peeling using
two different vital dyes, namely, membrane blue and mem-
brane blue dual. They concluded that membrane blue dual
led to better visual results probably due to better staining
and lesser toxicity, while there was no difference in MH clo-
sure rate between the two dyes. Furthermore, A. Bedda et al.
reported the anatomic and visual results of a new sutureless
illuminated macular buckle designed for patients with the
complex clinical situation of MH retinal detachment related
to high myopia with an axial length of >30mm. They
achieved aMH closure rate of 40% postoperatively with a sig-
nificant increase of visual acuity from 0.11 to 0.21 (decimal)
without complications in the 20 studied eyes.
Nevertheless, although themajority of surgical techniques
have been found to be safe and effective for VRI disease man-
agement, transient or permanent postoperative complications
have been reported. K.Ohta et al. supported that the postoper-
ative retinal nerve fiber layer (RNFL) was thicker in all but the
nasal-inferior sector for at least 12 months after combined
phacoemulsification and pars plana vitrectomy (PPV) with
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ILM peeling for patients with MH. This prolonged increase
of the RNFL thickness may indicate damage or mild edema
of the RNFL.
Finally, P. Stavrakas et al. in their retrospective study
evaluated the anatomic and functional outcomes of patients
with rhegmatogenous retinal detachment primarily treated
with PPV based on the location of the retinal breaks. The
authors found that there was no statistically significant differ-
ence between patients with superior and inferior breaks with
regard to primary retinal reattachment, mean visual acuity
change, and complication rate. Therefore, PPV alone can be
used to treat uncomplicated rhegmatogenous retinal detach-
ment irrespective to the location of the breaks, suggesting
that inferior breaks do not constitute an independent risk
factor for worse anatomic or functional outcome.
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